A B S T R A C T The ontogenesis of the hepatic glucagonsensitive adenylate cyclase system has been studied in the rat. With a partially purified liver membrane preparation, fetal adenylate cyclase was less responsive to glucagon than the enzyme from neonatal or adult livers.
INTRODUCTION
In the adult, glucagon plays a central role in the regulation of hepatic glycogenolysis and gluconeogenesis by activating the membrane-bound enzyme, adenylate cyclase, and increasing cyclic AMP concentrations (1, 2) .
During the perinatal period, however, the exact role of the hepatic adenylate cyclase system in the control of glucose homeostasis has not been clearly defined.
In the last third of gestation, fetal animals store glycogen in a variety of organs (3, 4) . At birth in the rat, there is an immediate increase in plasma glucagon and a decrease in plasma insulin concentrations (5, 6) , as well as a shift in hepatic carbohydrate metabolism from glycogen synthesis to glycogen breakdown and gluconeogenesis (3, 7) .
While alterations in the hormonal environment appear essential in the regulation of carbohydrate metabolism, the capacity of the liver to respond to these hormonal changes may be equally necessary in the maintenance of euglycemia during the neonatal period. Other investigators have demonstrated that before birth, fetal hepatic glycogenolytic and gluconeogenic enzyme systems are relatively insensitive to glucagon, but not to dibutyryl cAMP (8, 9) . In contrast, the neonatal hepatic adenylate cyclase system in the rat is very responsive to glucagon (10) (11) (12) , suggesting that the development of hepatic sensitivity to glucagon may be important in the establishment of neonatal glucose homeostasis.
In the present report, we have investigated the development of hepatic adenylate cyclase sensitivity to glucagon in partially purified membranes from fetal, neonatal, and adult rats.
The Journal of Clinical Investigation Volume 58 September 1976 -571-578 (14) . The preparation sequence was rigidly followed for membranes of all ages, and increases in the specific activity of the membrane marker enzyme. 5'-nucleotidase, were similar (15) ( Table I) . Membranes were storetl at -60'C for up to 3 mo without decrease in adenylate cyclase activity.
Adenylate cyclase assay
Adenylate cyclase activity was measured by a modification of the method of Pohl et al. (14) as previously described (16 NaPO, pH 7.4) with slow mixing for 30 s, and 100 4l of sodium metabisulfite (12 mg in 5 ml of 0.5 M NaPO., pH 7.4). 1 ml of 1 mM NaPO4, pH 7.4, was added and separation of`1-glucagon was carried out oy modification of the method of Rosselin et al. (20) . The entire reaction volume was adde(d to 30 mg of microfine silica (QUSO-G-32, Philadelphia Quartz Co., Philadelphia, Pa.), mixed, and centrifuged for 10 min at 1,000 g. The supernate was withdrawn and the pellet thoroughly resuspended in 2 ml of 1 mM NaPO4, pH 7.6, and centrifuged for 10 min at 1,000 g, and the supernatant was discarded. The pellet was again resuspended in 1.5 ml of 10 mNI NaPOI, 1% albumin, pH 10, and centrifuged for 10 mim at 1,000 q. The supernate, which contained 125I-glucagon, was saved. The iodinated hormone (sl) act 100-200 ,Ci/Ag) was chemically characterized by trichloroacetic acid precipitability (> 90% precipitation) and paper counterelectrophoresis (> 95% remained at the origin). Molar concentrations of 'I-glucagon were determined by activation of adenylate cyclase in adult, partially purified liver membranes, wvith unlabeled glucagon as standards. Yields of labeled glucagon were 30-50%. Aliquots of the iodinated hormone were frozen and used within 2 wk.
Glucagon binding assay
Bindling of I251-glucagon to liver membranes was assayed by a mo(lification of the method of Roclbell et al. (21) . Liver membranes were incubated with 1251-glucagon under conditions idlentical to the adenylate cyclase assay (see Methods). At the appropriate time, 50-,l aliquots were removed and layered on top of 300 4l ice-cold 2.5% albumin in 20 mM Tris-HCl, pH 7.6, in plastic microcentrifuge tubes. These tubes were centrifuged for 1 min at 10,000 g in a Beckman microcentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.), the supernate was aspirated, the pellet was carefully washed with 300 4l of ice-cold 10% sucrose, and the supernatant fluid was again aspirated. The tips of the centrifuge tubes were carefully cut off just above the pellet and the "SI-radioactivity remaining in the tips was determined. With each experiment, two controls were run: (a) incubation as above with I251-glucagon in the absence of liver membrane; the amount of radioactivity in the tip was always <1% of 22I counts added; (b) incubation as above, except that in addition to lI5I-glucagon, a 1,000-fold excess of cold glucagon was added; the difference between "I counts bound without and with excess cold glucagon represents nonspecific binding and was usually 
Glucagon degradation
Reaction A: degradation of 125I-glucagont by liver membranes. 'I-Glucagon was incubated with 150 jig of liver membrane under adenylate cyclase assay conditions (see Methods) (24) . At 5 min, the entire reaction volume (300 IAl) was rapidly transferred to a microfuge tube and centrifuged for 1 min at 10,000 g. 20 1"I-glucagon, it was assumed that glucagon had been degraded in reaction A. The percent of glucagon degraded was calculated by dividing the number of 'I counts no longer associated with biologically active 'I-glucagon by the total number of 12'I counts added to reaction A.
Adenylate cyclase kinetics
In partially purified liver membranes from animals of different ages, cyclic AMP formation was determined at varying concentrations of ATP in basal and glucagon-stimulated conditions. To insure linear cAMP formation at ATP concentrations less than 0.4 mM (data not shown), the reaction was allowed to proceed for only 4 min. Km and Vmax were determined by the Wilkinson formula (25) , and results were confirmed by least-squares analysis (26) and double-reciprocal plots (data not shown).
RESULTS
Effects of glucagon concentration on adenylate cylase activity. In experiments summarized in Fig. 1 clase is remarkably similar for the three ages, around 5 nM, the fetal membrane was less responsive than the 8-day neonatal or adult hepatic membrane at any glu- Effects of tissue preparation on adenylate cyclase activity. To investigate the possibility that some essential component of the fetal adenylate cyclase system was destroyed in the preparation of partially purified hepatic membranes, adenylate cyclase activity was determined in gently prepared liver homogenates from animals of varying age (Table II) . While glucagon significantly increased cAMP formation over basal at all ages studied, the 18-day fetal tissue was significantly less responsive than at other ages.
Effects of age on degradation of "'I-glucagon. To examine the possibility that enhanced glucagon degradation by the fetal hepatic membrane accounts for the apparent insensitivity of this tissue to this hormone, glucagon inactivation was studied (Fig. 2) . There appeared to be an age-dependent increase in the capacity of the liver membrane to inactivate glucagon: in contrast to the fetal tissue, which inactivated only 0 Effects of glucagon and NaF on adenylate cyclase activity. To investigate whether an insufficient quantity of the adenylate cyclase enzyme itself may account for the relative insensitivity of the fetal hepatic membrane to glucagon, adenylate cyclase activity was determined in response to maximal stimulating concentrations of glucagon, NaF, or both (Table III) (27) . Similar results were obtained in these studies, in which maximal concentrations of fluoride and glucagon failed to stimulate this enzyme more than fluoride alone.
Effects of age on adenylate cyclase activity and "Iglucagon binding. In Fig. 3 pmol/mg protein per 5 min. Adenylate cyclase kinetics. Under our assay conditions, there were no statistical differences among the Km's for ATP in fetal and neonatal partially purified membranes (Fig. 5) . In contrast, development of glucagon binding was expressed primarily as an increase in maximum velocity of cAMP formation: 986±85 (20- day fetal) vs. 5,028+403 (6-day neonatal) pmol cAMP formed/mg protein per 4 min.
DISCUSSION
Before birth, fetal gluconeogenic and glycogenolytic capacities are severely limited (9, 28) ; fetal plasma glucose concentrations are maintained by transfer of glucose from mother to fetus (3). To maintain euglycemia at birth, the animal must (a) store a potential glucose source, e.g. glycogen, before birth for use during the initial neonatal period; (b) alter the hormonal environment so that endogenous glucose formation is maximal; and (c) develop the hepatic capacity for glycogenolysis and gluconeogenesis in response to hormonal stimulation. Previous investigations have documented prenatal glycogen storage (3, 4) and a postnatal catabolic hormonal milieu (5, 6, 29) . The development of the capacity of the neonatal liver to respond to one of these catabolic hormones, glucagon, is the subject of the present report.
The results of our studies indicate that whereas the 18-day fetal hepatic adenylate cyclase system can respond to glucagon at a concentration greater than 1 nM, this response is quite limited when compared to that of neonatal and adult animals, both in quantity of cyclic AMP formed and sensitivity to glucagon. Relative fetal hepatic adenylate cyclase insensitivity to glucagon has been observed by others in liver homogenates (11, 30) , particles (10) , and slices (10) , and in vivo (10, 12) . This lack of response to glucagon, together with a high insulin-glucagon ratio (31), would insure glycogen storage during the last third of gestation.
Several reasons could explain the relative unresponsiveness of the fetal hepatic adenylate cyclase to glucagon. Friedman et al. have indicated that purification of fetal lamb myocardial tissues damages the glucagon-responsive adenylate cyclase system (32) . Destruction of a component of the fetal adenylate cyclase system during preparation of partially purified membranes seems an unlikely explanation from our results, however, because similar observations of fetal hepatic unresponsiveness to glucagon have been made in gently prepared liver homogenates (Table II) (11) , in intact livers (10) , and in liver slices (10) , conditions in which tissue damage should be negligible.
Differences in the cellular composition of the fetal liver may explain the relative unresponsiveness of this tissue to glucagon compared to neonatal liver. Very few hematopoietic and reticulo-endothelial cellular elements are present in the liver in the late gestational and early newborn period. However, and at most, there is a two-to fourfold increase in hepatocytes after birth (33, 34) . In contrast, changes in adenylate cyclase responsiveness to glucagon in the perinatal period are 50-fold (Fig. 3) , suggesting real changes in the capacity of the liver membrane to respond to the hormone.
Pohl et al. have documented the existence of a potent hepatic glucagon-degradation system (24) . Furthermore, evidence exists that the hepatic adenylate cyclase and glucagon degradation systems are independent processes (35, 36) . Studies of glucagon degradation (Fig. 2) . however, indicate that enhanced hormone degradation by the fetal liver does not occur and thus cannot explain the relative unresponsiveness of this membrane to glucagon.
An insufficient quantity of adenylate cyclase enzyme itself might account for the insensitivity of the fetal hepatic membrane to glucagon. As noted by others (10, 11) , however, the fetal adenylate cyclase system is very responsive to NaF and, in our system, more sensitive than in neonatal or adult tissue. Since fluoride and glucagon appear to act on the same adenylate cyclase enzyme in the liver (27, (Fig. 4) . Furthermore, these changes in glucagon-binding were accompanied primarily by increases in the maximum velocity of cAMP formation (Fig. 5) , perhaps due to activation of more adenylate cyclase enzyme molecules.
Recent investigations that indiacte (a) a dissociation between rates of glucagon-stimulated hepatic adenylate cyclase activation and 'I-glucagon binding (37) ; and (b) binding of hormones to nonreceptor materials (38) suggest that one must be exceedingly careful in the interpretation of hormone binding studies. Similarly, the application of our results to other species or disease states must be done with caution. Nevertheless, possible consequences of delayed hepatic responsiveness to glucagon deserve comment. Offspring of diabetic mothers are prone to develop severe neonatal hypoglycemia (39) , presumably due to hyperinsulinemia (40) , and an inadequate glucagon response to this hypoglycemia (41) . Experimental evidence suggests that hormone induction of gluconeogenic and glycogenolytic enzymes can be blocked by hyperglycemia (9, 42) . If glucagon's effect on these enzymes is mediated via cAMP, hyperglycemia may delay the normal development of hepatic adenylate cyclase responsiveness to glucagon and thus contribute to the profound hypoglycemia observed in offspring of diabetic mothers.
"Small-for-gestation" infants are also at risk for the development of hypoglycemia (43, 44) . This "hypoglycemic potential" appears not to be due to defects in hormone secretion, including glucagon (45, 46) or lack of potential glucose substrates (45) . Rather, hepatic enzyme induction by glucagon may be limited in these small-for-gestation infants (45) . In normal-weight newborns, gluconeogenic (47) , hyperglycemic, and urinary cAMP responses (48) to pharmacological doses of glucagon do not reach maturity until 3-4 days of life. This same immaturity of hepatic responsiveness may be exaggerated in small-for-gestational infants and reflect delayed development of glucagon-stimulated hepatic adenylate cyclase system. Clearly, further work is necessary to validate this hypothesis.
Our findings suggest that the development of hepatic adenylate cyclase responsiveness to glucagon may be important in the normal developmental pattern of carbohydrate homeostasis: in the fetal period, a relative lack of adenylate cyclase responsiveness to glucagon would favor glycogen storage; in the neonatal period, development of glucagon binding is correlated with heightened sensitivity of adenylate cyclase to glucagon, a situation optimal for endogenous glucose formation via glycogenolysis and gluconeogenesis.
The cellular factors involved in the ontogenesis of hepatic responsiveness to glucagon, the signal for the development of functional hepatic glucagon receptors, the influence of environmental factors (e.g. hyperglycemia) on neonatal adenylate cyclase sensitivity to glucagon, and the relationship of these events to human physiology and disease will require further investigation.
